Association of sex hormones and C-reactive protein levels in men

Clinical Endocrinology

Volumn 72, Issue 4, 2010, Pages 527-533

  Kupelian, Varant ^a   Chiu, Gretchen R ^a   Araujo, Andre B ^a   Williams, Rachel E ^b   Clark, Richard V ^b   McKinlay, John B ^a  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ESTRADIOL; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; COMORBIDITY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; GROUPS BY AGE; HORMONE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; RACE DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGING; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ESTRADIOL; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 77749255227     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03713.x     Document Type: Article

References (30)

1. Feldman, H.A., Longcope, C., Derby, C.A. et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. The Journal of Clinical Endocrinology and Metabolism, 87, 589 598.
2. Ridker, P.M. (2007) C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. Journal of the American College of Cardiology, 49, 2129 2138.
3. Ferrucci, L., Corsi, A., Lauretani, F. et al. (2005) The origins of age-related proinflammatory state. Blood, 105, 2294 2299.
4. Khosla, S., Atkinson, E.J., Dunstan, C.R. et al. (2002) Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. The Journal of Clinical Endocrinology and Metabolism, 87, 1550 1554.
5. Maggio, M., Basaria, S., Ble, A. et al. (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. The Journal of Clinical Endocrinology and Metabolism, 91, 345 347.
6. Nakhai Pour, H.R., Grobbee, D.E., Muller, M. et al. (2007) Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clinical Endocrinology, 66, 394 398.
7. Malkin, C.J., Pugh, P.J., Jones, R.D. et al. (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. The Journal of Clinical Endocrinology and Metabolism, 89, 3313 3318.
8. Nakhai-Pour, H.R., Grobbee, D.E., Emmelot-Vonk, M.H. et al. (2007) Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial. American Heart Journal, 154, 1228, e1221-e1227.
9. McKinlay, J.B. Link, C.L. (2007) Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) survey. European Urology, 52, 389 396.
10. Sodergard, R., Backstrom, T., Shanbhag, V. et al. (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. Journal of Steroid Biochemistry, 16, 801 810.
11. Prasad, K. (2006) C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews, 24, 33 50.
12. Laaksonen, D.E., Niskanen, L., Punnonen, K. et al. (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. European Journal of Endocrinology, 149, 601 608.
13. Bhatia, V., Chaudhuri, A., Tomar, R. et al. (2006) Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care, 29, 2289 2294.
14. Maggio, M., Ceda, G.P., Lauretani, F. et al. (2009) Estradiol and inflammatory markers in older men. The Journal of Clinical Endocrinology and Metabolism, 94, 518 522.
15. Van Pottelbergh, I., Braeckman, L., De Bacquer, D. et al. (2003) Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis, 166, 95 102.
16. Ng, M.K., Liu, P.Y., Williams, A.J. et al. (2002) Prospective study of effect of androgens on serum inflammatory markers in men. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1136 1141.
17. Kapoor, D., Clarke, S., Stanworth, R. et al. (2007) The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 156, 595 602.
18. Kovacs, A., Henriksson, P., Hamsten, A. et al. (2005) Hormonal regulation of circulating C-reactive protein in men. Clinical Chemistry, 51, 911 913.
19. Liu, P.Y., Death, A.K. Handelsman, D.J. (2003) Androgens and cardiovascular disease. Endocrine Reviews, 24, 313 340.
20. Laaksonen, D.E., Niskanen, L., Punnonen, K. et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27, 1036 1041.
21. Stellato, R.K., Feldman, H.A., Hamdy, O. et al. (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care, 23, 490 494.
22. Ding, E.L., Song, Y., Malik, V.S. et al. (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. The Journal of the American Medical Association, 295, 1288 1299.
23. Maggio, M., Lauretani, F., Ceda, G. et al. (2008) Estradiol and metabolic syndrome in older Italian men: the InCHIANTI study. Journal of Andrology doi :.
24. Muller, M., Grobbee, D.E., den Tonkelaar, I. et al. (2005) Endogenous sex hormones and metabolic syndrome in aging men. The Journal of Clinical Endocrinology and Metabolism, 90, 2618 2623. (Pubitemid 40686299)
25. Arnlov, J., Pencina, M.J., Amin, S. et al. (2006) Endogenous sex hormones and cardiovascular disease incidence in men. Annals of Internal Medicine, 145, 176 184.
26. Barrett-Connor, E. Khaw, K.T. (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation, 78, 539 545. (Pubitemid 18211274)
27. Yarnell, J.W., Beswick, A.D., Sweetnam, P.M. et al. (1993) Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology/American Heart Association, 13, 517 520.
28. Abbott, R.D., Launer, L.J., Rodriguez, B.L. et al. (2007) Serum estradiol and risk of stroke in elderly men. Neurology, 68, 563 568.
29. Tivesten, A., Hulthe, J., Wallenfeldt, K. et al. (2006) Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. The Journal of Clinical Endocrinology and Metabolism, 91, 4433 4437.
30. Okura, Y., Urban, L.H., Mahoney, D.W. et al. (2004) Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. Journal of Clinical Epidemiology, 57, 1096 1103.